Xiao-Hong Han (Xiaohong Han)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

High Performance Liquid Chromatography

Top Venues

Cancer immunology, immunotherapy : CII

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, Ruili Pan, Qi He, Xiaobei Guo, Siyuan Yu, Na Wang, Qian Zhao, Mengzhao Wang, Yan Xu, Xiao-Hong Han
Immune responses and reinfection of SARS-CoV-2 Omicron variant in patients with lung cancer. International journal of cancer 155 (8) (2024)
Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang, Jianliang Yang, Puyuan Xing, Sheng Yang, Dan Wang, Guibing Wang, Shasha Wang, Jiarui Yao, Zhishang Zhang, Le Tang, Xiaobo Yu, Xiao-Hong Han, Yuan-Kai Shi
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang, Jianliang Yang, Puyuan Xing, Sheng Yang, Dan Wang, Guibing Wang, Shasha Wang, Jiarui Yao, Zhishang Zhang, Le Tang, Xiaobo Yu, Xiao-Hong Han, Yuan-Kai Shi
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang, Jianliang Yang, Puyuan Xing, Sheng Yang, Dan Wang, Guibing Wang, Shasha Wang, Jiarui Yao, Zhishang Zhang, Le Tang, Xiaobo Yu, Xiao-Hong Han, Yuan-Kai Shi
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang, Jianliang Yang, Puyuan Xing, Sheng Yang, Dan Wang, Guibing Wang, Shasha Wang, Jiarui Yao, Zhishang Zhang, Le Tang, Xiaobo Yu, Xiao-Hong Han, Yuan-Kai Shi
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, Ruili Pan, Qi He, Xiaobei Guo, Siyuan Yu, Na Wang, Qian Zhao, Mengzhao Wang, Yan Xu, Xiao-Hong Han
Immune responses and reinfection of SARS-CoV-2 Omicron variant in patients with lung cancer. International journal of cancer (2024)
Qiaoyun Tan, Ruyun Gao, Xiaomei Zhang, Jianliang Yang, Puyuan Xing, Sheng Yang, Dan Wang, Guibing Wang, Shasha Wang, Jiarui Yao, Zhishang Zhang, Le Tang, Xiaobo Yu, Xiao-Hong Han, Yuan-Kai Shi
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Jianwei Ren, Yufang Ma, Mingsheng Ma, Juan Ding, Jingjing Jiang, Xin Zheng, Xiao-Hong Han
Development of a rapid simultaneous assay of two urinary tetrasaccharide metabolites using differential ion mobility and tandem mass spectrometry and its application to patients with glycogen storage disease (type Ib and II). Analytical and bioanalytical chemistry (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Jian-Wei Ren, Xin Zheng, Xiao-Hong Han
Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. Molecules (Basel, Switzerland) 28 (5) (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer 130 (8) (2023)
Chen Chen, Ruili Pan, Liyuan Dai, Minjiang Chen, Jing Zhao, Wei Zhong, Mengzhao Wang, Hongsheng Liu, Yan Xu, Xiao-Hong Han
The Presence of Lung Cancer Affects SARS-CoV-2 Vaccine Uptake and Attitude in Chinese Patients: A Clinical Cross-Sectional Investigation. Cancer investigation (2023)
Jian-Wei Ren, Xin Zheng, Xiao-Hong Han
Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. Molecules (Basel, Switzerland) 28 (5) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Jian-Wei Ren, Xin Zheng, Xiao-Hong Han
Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry. Molecules (Basel, Switzerland) 28 (5) (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer 130 (8) (2023)
Rongrong Luo, Pei Zhong, Xiying Li, Juan Cai, Yimin Tao, Bangzhu Xiong, Hancheng Zheng, Zhishang Zhang, Le Tang, Jiarui Yao, Yingrui Li, Yuan-Kai Shi, Xiao-Hong Han
High-throughput peptide arrays identify potential diagnostic autoantibody signatures in early-stage lung adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics (2023)
Liling Huang, Tongji Xie, Fuqiang Zhao, Yu Feng, Hao-Hua Zhu, Le Tang, Xiao-Hong Han, Yuan-Kai Shi
DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis. Disease markers 2022 (2022)
Ning Lou, Cuiling Zheng, Yanrong Wang, Caixia Liang, Qiaoyun Tan, Rongrong Luo, Lei Zhang, Tongji Xie, Yuankai Shi, Xiao-Hong Han
Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays. Cancer immunology, immunotherapy : CII (2022)
Rongrong Luo, Cuiling Zheng, Wenya Song, Qiaoyun Tan, Yuan-Kai Shi, Xiao-Hong Han
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes. Cancer science (2021)